Biodegradable Self-Powered Electrotherapy Patch for Integrated Smart Wound Management

Clinical Snapshot

Key Findings

• P Value: Not reported in abstract.

• Effect Size: Not reported in abstract; no quantitative wound closure rates, cell alignment indices, or healing time differences provided.

• Primary Outcome: In vivo: combination ES therapy 'dramatically accelerates wound healing' in Sprague-Dawley rat model. In vitro: applied electric field 'significantly promotes cell-directed alignment' relevant to tissue regeneration and remodelling.

• Nnt Or Sensitivity: Not applicable at preclinical stage. Biosensor sensitivity metrics described as 'sensitive' but specific limits of detection, sensitivity, and selectivity values not provided in abstract.

• Confidence Interval: Not reported.

Clinical Application

Clinical translation requires: (1) first-in-human safety studies; (2) TGA regulatory approval as a Class IIb or III medical device; (3) demonstration of manufacturing scalability and cost-effectiveness; (4) integration with existing wound care workflows. Current feasibility is limited to research laboratory settings. Australia has a significant chronic wound burden, with an estimated 420,000 Australians affected annually at a cost exceeding AUD 3 billion (Wounds Australia data). Current PBS-listed wound management products do not include electrotherapy patches of this type. The TGA would classify such a device under the Therapeutic Goods (Medical Devices) Regulations 2002, requiring conformity assessment before market entry. RACGP and Wounds Australia guidelines currently recommend evidence-based dressings and offloading for chronic wounds; electrotherapy has limited supporting evidence in existing guidelines. This technology is not PBS-reimbursable and has no current TGA registration. Australian researchers and clinicians should monitor this space for future clinical trial opportunities. Not currently applicable to any clinical population. Potential future relevance to patients with acute and chronic wounds, including surgical wounds, diabetic foot ulcers, pressure injuries, and venous leg ulcers, pending human clinical trial evidence.

Abstract

Smart patches based on multimodal wearable devices enable real-time physiologic monitoring and proactive interventions to promote wound healing. Herein, we describe a biodegradable wearable electrotherapy patch (E-patch) that integrates noninvasive self-powered electrical stimulation (ES) therapy for tissue regeneration and a multiplexed electrochemical biosensor array for continuous monitoring of wound status. Custom-developed supercapacitor arrays (SCs) supply stable energy for ES, and constructed wearable biosensors enable sensitive monitoring of biomarkers in the wound exudate. As-fabricated wearable E-patches degrade harmlessly after operation, significantly reducing the environmental pollution pressure associated with flexible electronics. In vitro studies demonstrated that an applied electric field (EF) significantly promotes cell-directed alignment, which is crucial for tissue regeneration and remodeling. In vivo investigations in the Sprague-Dawley (SD) rat model illustrate that combination therapy dramatically accelerates wound healing. Overall, this work provides a promising strategy toward integrated smart wound management and future feedback-assisted wearable therapeutic systems.

References

1. 1.Zhang, W., Lin, Q., Hu, Y., Zhang, J., Mo, H., Li, W., Zhang, L., Yu, H., & Zhu, N. (2026). Biodegradable self-powered electrotherapy patch for integrated smart wound management. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02562